{"results": [{"id": "0000882796:2011:FY", "start_date": "2011-01-01", "end_date": "2011-12-31", "filing_date": "2012-03-06", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2011", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-12-098926", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-12-098926/files/bcrx-20111231.xml", "financials": {"balance_sheet": {"equity_attributable_to_parent": {"value": 14806000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 52858000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 1098000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "assets": {"value": 82208000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 41103000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_than_fixed_noncurrent_assets": {"value": 28252000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 29350000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 26299000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 14806000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 82208000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 67402000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 2822000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 23755000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 11318000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -32251000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 23755000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 2822000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 11318000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -32251000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"revenues": {"value": 19643000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -49587000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -49587000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -56948000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -56948000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 69230000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 69230000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "interest_expense_operating": {"value": 3774000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "costs_and_expenses": {"value": 69230000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -56948000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -56948000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -56948000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -56948000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"id": "0000882796:2012:FY", "start_date": "2012-01-01", "end_date": "2012-12-31", "filing_date": "2013-03-11", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2012", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-13-100999", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-13-100999/files/bcrx-20121231.xml", "financials": {"income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -39081000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 26293000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 60181000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 60181000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 4666000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_expenses": {"value": 60181000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -39081000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -39081000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -39081000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -33888000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -33888000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "interest_and_debt_expense": {"value": 4666000.0, "unit": "USD", "label": "Interest And Debt Expense", "order": 2500}}, "balance_sheet": {"equity": {"value": -454000, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 583000, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 57439000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_than_fixed_noncurrent_assets": {"value": 14878000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_liabilities": {"value": 40669000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": -454000, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 57439000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 41978000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 15461000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 57893000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 17224000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 24884000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 4447000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -37397000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 4447000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 24884000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 16960000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -37397000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 16960000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -39094000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -39094000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -13000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"id": "0000882796:2013:FY", "start_date": "2013-01-01", "end_date": "2013-12-31", "filing_date": "2014-03-10", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2013", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-14-091609", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-14-091609/files/bcrx-20131231.xml", "financials": {"income_statement": {"operating_expenses": {"value": 48048000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -30108000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 48048000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -30717000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -30108000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 17331000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -30717000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -30108000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -30108000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "interest_expense_operating": {"value": 4778000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "costs_and_expenses": {"value": 48048000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -26530000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 273000, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -26530000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -3467000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 30270000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -3467000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 273000, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 30270000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -23000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -30131000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -30131000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"assets": {"value": 48866000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_than_fixed_noncurrent_assets": {"value": 6439000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 42121000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 49992000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 6745000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 48866000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 34736000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 15256000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 306000, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity": {"value": -1126000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": -1126000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}, {"id": "0000882796:2014:FY", "start_date": "2014-01-01", "end_date": "2014-12-31", "filing_date": "2015-03-02", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2014", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-15-001186", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-15-001186/files/bcrx-20141231.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": 33376000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -39980000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 33376000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -38551000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -38551000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 111907000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -39980000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 111907000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 207000, "unit": "USD", "label": "Fixed Assets", "order": 400}, "current_assets": {"value": 89343000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 75635000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 3552000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 136874000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 61239000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 47531000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 57687000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_than_fixed_noncurrent_assets": {"value": 47324000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity": {"value": 75635000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 136874000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -45189000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 59378000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -45771000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "gross_profit": {"value": 13607000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "operating_income_loss": {"value": -45771000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "cost_of_revenue_goods": {"value": 1000, "unit": "USD", "label": "Cost Of Revenue, Goods", "order": 400}, "interest_expense_operating": {"value": 4998000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "cost_of_revenue": {"value": 1000, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "costs_and_expenses": {"value": 59379000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -45189000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -45189000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -45189000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": 17312000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 13608000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 59379000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -134000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -45323000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -45323000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"id": "0000882796:2015:FY", "start_date": "2015-01-01", "end_date": "2015-12-31", "filing_date": "2016-02-26", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2015", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-16-008207", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-16-008207/files/bcrx-20151231.xml", "financials": {"income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "cost_of_revenue_goods": {"value": 1368000.0, "unit": "USD", "label": "Cost Of Revenue, Goods", "order": 400}, "income_loss_from_continuing_operations_before_tax": {"value": -39444000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -43019000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "cost_of_revenue": {"value": 1368000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "benefits_costs_expenses": {"value": 87701000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 86333000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -43019000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "costs_and_expenses": {"value": 87701000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 5200000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_from_continuing_operations_after_tax": {"value": -43019000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.5900000000000001, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "gross_profit": {"value": 46889000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "revenues": {"value": 48257000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.5900000000000001, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -43019000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -39444000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -43095000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -43095000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -76000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"assets": {"value": 124555000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 47724000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 64453000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 12378000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 58565000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_than_fixed_noncurrent_assets": {"value": 53416000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 65990000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 76831000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 124555000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 47724000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 5149000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 5479000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -25641000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -13116000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -18004000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -13116000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 5479000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -18004000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -25641000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"id": "0000882796:2016:FY", "start_date": "2016-01-01", "end_date": "2016-12-31", "filing_date": "2017-02-27", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2016", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-17-001159", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-17-001159/files/bcrx-20161231.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 23339000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 23304000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -53438000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -6795000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -53438000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 23304000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -6795000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 23339000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 194000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -54950000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -54950000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -55144000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -48607000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "cost_of_revenue": {"value": 2297000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -55144000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "gross_profit": {"value": 24056000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_expense_operating": {"value": 6487000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "benefits_costs_expenses": {"value": 74960000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 72663000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -55144000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -48607000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": 74960000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 26353000.0, "unit": "USD", "label": "Revenues", "order": 100}, "cost_of_revenue_goods": {"value": 2297000.0, "unit": "USD", "label": "Cost Of Revenue, Goods", "order": 400}, "net_income_loss_attributable_to_parent": {"value": -55144000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "balance_sheet": {"assets": {"value": 89847000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 88269000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 66987000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 33909000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 1578000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 54360000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 1578000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 9922000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_assets": {"value": 22860000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_than_fixed_noncurrent_assets": {"value": 12938000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 89847000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}}}, {"id": "0000882796:2017:FY", "start_date": "2017-01-01", "end_date": "2017-12-31", "filing_date": "2018-03-12", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2017", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-18-001855", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-18-001855/files/bcrx-20171231.xml", "financials": {"income_statement": {"benefits_costs_expenses": {"value": 82597000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 82597000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": -65782000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "cost_of_revenue": {"value": 1142000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "operating_income_loss": {"value": -57411000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -65782000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -65782000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "gross_profit": {"value": 24044000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "interest_expense_operating": {"value": 8565000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "revenues": {"value": 25186000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -57411000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 81455000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -65782000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "cost_of_revenue_goods": {"value": 1142000.0, "unit": "USD", "label": "Cost Of Revenue, Goods", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -66382000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -41143000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 28178000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -41143000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 135703000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -66382000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 28178000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 135703000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -66013000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -231000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -66013000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity": {"value": 83767000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 9546000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_parent": {"value": 83767000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 178259000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 19656000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_than_fixed_noncurrent_assets": {"value": 43322000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_liabilities": {"value": 74836000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 125391000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 178259000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 94492000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 52868000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}}}, {"id": "0000882796:2018:FY", "start_date": "2018-01-01", "end_date": "2018-12-31", "filing_date": "2019-03-14", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2018", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-19-001727", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-19-001727/files/bcrx-20181231.xml", "financials": {"balance_sheet": {"fixed_assets": {"value": 9135000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_assets": {"value": 32489000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 146841000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 97606000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 49235000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 49235000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 146841000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_than_fixed_noncurrent_assets": {"value": 23354000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 114352000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 69477000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 28129000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "income_statement": {"interest_expense_operating": {"value": 9176000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss": {"value": -101252000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -101252000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -101252000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 114873000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 20653000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -101252000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -94220000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -94220000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 114873000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 114873000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -54000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -101306000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -101306000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -92565000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 62504000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -25293000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 4768000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 4768000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 62504000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -92565000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -25293000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"id": "0000882796:2019:FY", "start_date": "2019-01-01", "end_date": "2019-12-31", "filing_date": "2020-03-13", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2019", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-20-001710", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-20-001710/files/bcrx-20191231.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -108561000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -108561000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 336000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"equity": {"value": 38252000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 44695000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_than_fixed_noncurrent_assets": {"value": 3590000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "fixed_assets": {"value": 7347000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "current_liabilities": {"value": 92335000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 175282000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 38252000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 10937000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 164345000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 175282000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 137030000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "income_statement": {"benefits_costs_expenses": {"value": 148290000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -108897000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": -108897000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "cost_of_revenue": {"value": 3726000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "costs_and_expenses": {"value": 148290000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -99455000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -99455000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -108897000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 48835000.0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_expense_operating": {"value": 11892000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss": {"value": -108897000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "gross_profit": {"value": 45109000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "operating_expenses": {"value": 144564000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 99098000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 77934000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 87448000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 77934000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -89584000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -89584000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 99098000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 87448000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"id": "0000882796:2020:FY", "start_date": "2020-01-01", "end_date": "2020-12-31", "filing_date": "2021-03-01", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2020", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-21-001411", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-21-001411/files/bcrx20201231_10k_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -182850000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -182850000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -36000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"cost_of_revenue": {"value": 1550000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "operating_expenses": {"value": 191019000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 17812000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -182814000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -182814000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -174757000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_before_equity_method_investments": {"value": -182814000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -182814000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": -182814000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -182814000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 200626000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_expense_operating": {"value": 14501000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "costs_and_expenses": {"value": 192569000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "gross_profit": {"value": 16262000.0, "unit": "USD", "label": "Gross Profit", "order": 800}}, "balance_sheet": {"current_assets": {"value": 323800000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": -19262000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": -19262000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 334715000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_than_fixed_noncurrent_assets": {"value": 3802000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "assets": {"value": 334715000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 105654000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 10915000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 353977000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 7113000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_liabilities": {"value": 248323000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -6856000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 302697000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -137216000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -6856000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 158625000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 158625000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -137216000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 302697000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}, {"id": "0000882796:2021:FY", "start_date": "2021-01-01", "end_date": "2021-12-31", "filing_date": "2022-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2021", "cik": "0000882796", "sic": "2836", "tickers": ["BCRX"], "company_name": "BIOCRYST PHARMACEUTICALS INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001171843-22-001460", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001171843-22-001460/files/bcrx20211231_10k_htm.xml", "financials": {"balance_sheet": {"current_liabilities": {"value": 103718000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 588151000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": -106986000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": -106986000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 566136000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 588151000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_than_fixed_noncurrent_assets": {"value": 13301000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities": {"value": 695137000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 8714000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_assets": {"value": 22015000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 591419000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"income_tax_expense_benefit": {"value": 2253000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": -184062000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "gross_profit": {"value": 149941000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -184062000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -177720000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 157170000.0, "unit": "USD", "label": "Revenues", "order": 100}, "interest_expense_operating": {"value": 59294000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "cost_of_revenue": {"value": 7229000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 334890000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -181809000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 338979000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -184062000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -184062000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 327661000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 174000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -183888000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -183888000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -142157000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "exchange_gains_losses": {"value": 71000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities": {"value": 15804000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -142157000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 359668000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 233315000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 233386000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 15804000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 359668000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}}}], "status": "OK", "request_id": "39368e52cecc2a4267358d8eeb6b89fa"}